Detection of hepatitis C virus RNA in saliva of patients with active infection not associated with periodontal or liver disease severity

• Published in: BMC infectious diseases 2014-02, Vol.14 (1), p.72-72, Article 72
• Main Authors: Sosa-Jurado, Francisca, Hernández-Galindo, Verónica L, Meléndez-Mena, Daniel, Mendoza-Torres, Miguel A, Martínez-Arroniz, Fernando J, Vallejo-Ruiz, Verónica, Reyes-Leyva, Julio, Santos-López, Gerardo
• Format: Article
• Language: English
• Subjects: Adult; Analysis; Blood transfusion; Carcinoma, Hepatocellular - virology; Care and treatment; Dental Plaque - complications; Diagnosis; Disease transmission; Epidemiology; Female; Gastroenterology; Gum disease; Health aspects; Hepacivirus; Hepatitis; Hepatitis C - transmission; Hepatitis C - virology; Hepatitis C virus; HIV; Human immunodeficiency virus; Humans; Infections; Liver Cirrhosis - virology; Liver diseases; Liver Neoplasms - virology; Male; Medical research; Medicine, Experimental; Middle Aged; Periodontal Diseases - complications; Physiological aspects; Polymerase Chain Reaction; Risk Factors; RNA, Viral - analysis; Saliva - virology; Substance abuse treatment; Viral Load
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/1471-2334-14-72

Hepatitis C virus (HCV) is mainly transmitted by parenteral route, being blood transfusion and intravenous drug use the most frequent risk factors. However, it has been suggested that there are other routes of transmission. There are several studies where HCV RNA has been detected in saliva of patients infected with HCV, and epidemiological studies have proposed the dental treatments as possible risk factors for HCV transmission. The purpose of this study was to detect the presence of HCV RNA in saliva of patients with active infection and associating with periodontal or liver disease. Patients with quantifiable HCV-RNA in serum were enrolled in the study. Periodontal disease was assessed using the modified gingival index (MGI). Presence of dental plaque was assessed with the use of disclosing tablets. Patients were clinically and laboratory evaluated to identify the stage of liver disease, the HCV RNA was determinate in saliva by nested RT-PCR. To determine associations between different parameters univariate and multivariate analysis were used. A total of 45 patients were included. Of these patients, 21 (46.6%) had hepatitis, 23 (51.1%) had cirrhosis and one patient (2.4%) presented hepatocellular carcinoma (HCC). Viral loads in serum ranged from 2.31-6.68 log IU/ml with a mean of 5.46 log IU/ml (95% CI 5.23-5.70). HCV RNA was positive in saliva of 29 patients (64.4%) and was not detected in 16 (35.6%). For univariate analysis three independent variables were associated with the detection of HCV-RNA in saliva: gender, viral load and dental plaque and multivariate analysis only one independent variable viral load >5.17 log IU/mL remained significantly associated with the detection of HCV in saliva (p = 0.0002). A statistical difference was observed when viral load was analyzed, log 5.85 IU/mL (95% CI 5.67-6.02) for patients with HCV in saliva vs. log 4.77 IU/mL (95% CI 4.35-5.19) for patients without HCV in saliva (p = 0.0001). The detection of HCV-RNA in saliva was more frequent in patients with relatively high serum viral loads. HCV-RNA in saliva was associated with the level of serum viral load but not with periodontal or liver disease severity.